July 16, 2018 — Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: MRRBF) is pleased to announce that its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), has entered into a Memorandum of Understanding (“MOU”) with the British Columbia (“BC”) Liquor Distribution Branch (“LDB”) to supply Experion branded cannabis products for sale in the province’s adult use market once legalization takes effect on October 17, 2018.
“The BC LDB agreement is the first formal supply agreement signed by Experion, making this a big milestone win for the team. We are very proud to be one of the 12 BC-based distributors to join the BC LDB platform,” said Jarrett Malnarich, Chief Executive Officer of Viridium.
Experion will supply the BC market with cannabis products when adult use sale becomes legal on October 17, 2018. Experion will cultivate the products to be supplied to the BC LDB at Experion’s facility outside of Mission, BC. The agreement will allow the Company to improve awareness of Experion and its products as they are distributed in retail stores across BC. Viridium is continuing discussions with additional potential supply partners and hopes to build upon this supply agreement win.
“We are thrilled to be reaching this significant milestone in developing a competitive wholesale assortment for non-medical cannabis,” said Blain Lawson, BC LDB’s general manager and CEO. “The volume, variety and quality of our product assortment speak to the LDB’s commitment to working towards eliminating the illicit market.”
Viridium Pacific Group Ltd. is a biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production (Experion Biotechnologies), property development (Fish Trap Ventures Ltd.), and human resource management (Stave Lake Services Ltd.). Experion Biotechnologies Inc. is a Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company’s profile on SEDAR at www.sedar.com.
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.